Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Adicet Bio Inc (NQ: ACET )

1.875 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.875
Bid (Size) 1.900 (26)
Ask (Size) 2.130 (1)
Prev. Close 1.875
Today's Range 1.875 - 1.875
52wk Range 1.100 - 7.500
Shares Outstanding 42,957,586
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference
From Adicet Bio, Inc.
Via Business Wire

Performance

YTD
-6.72%
-6.72%
1 Month
-14.77%
-14.77%
3 Month
-21.87%
-21.87%
6 Month
+53.69%
+53.69%
1 Year
-69.16%
-69.16%

More News

Read More
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio: Q4 Earnings Insights
Via Benzinga
The Penny Stock A-List: 7 High-Profile Companies on the Verge of Greatness
Via InvestorPlace
ACET Stock Earnings: Adicet Bio Meets EPS for Q4 2023
Via InvestorPlace
Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio to Participate in a Fireside Chat at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
From Adicet Bio, Inc.
Via Business Wire
3 High-Risk Stocks That Could Pay Off in the Millions
Via InvestorPlace
Topics Stocks
Exposures US Equities
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
7 Top-Tier Penny Stocks for a Smart Bet
Via InvestorPlace
Topics Stocks
Exposures US Equities
7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
Via InvestorPlace
Adicet Bio to Participate in a Fireside Chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio, Inc. Announces Closing of $98 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
From Adicet Bio, Inc.
Via Business Wire
Adicet Bio, Inc. Announces Pricing of Public Offering
From Adicet Bio, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Adicet Bio, Inc. Announces Proposed Public Offering
From Adicet Bio, Inc.
Via Business Wire
IN8bio's Phase 1 Clinical Trial Of INB-100 Offers Hope To Leukemia Patients With Promising Data
Via Benzinga
Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Via Benzinga
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.